Basic Information
| RNALocate ID: | RLID:11002506 |
| RNA Symbol: | hsa-miR-376a-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-376a-3p |
| RNA ID: | miRBase:MIMAT0000729 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002038 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11002504 | Exosome | HCC cell line (Hep3B|HepG2|PLC/PRF/5) | 21721029 |
| RLID:11002505 | Exosome | Brain tissue | 23382797 |
| RLID:11002507 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000417 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001205 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-376a-3p | Oral squamous cell carcinoma | MNDR-E-MI-45948 |
| MNDR | hsa-miR-376a-3p | Medulloblastoma | MNDR-E-MI-45949 |
| MNDR | hsa-miR-376a-3p | Lymphoma | MNDR-E-MI-45950 |
| MNDR | hsa-miR-376a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-45951 |
| MNDR | hsa-miR-376a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-45952 |
| MNDR | hsa-miR-376a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-45953 |
| MNDR | hsa-miR-376a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-45954 |
| MNDR | hsa-miR-376a-3p | Her2-receptor positive breast cancer | MNDR-E-MI-45955 |
| MNDR | hsa-miR-376a-3p | Breast cancer luminal | MNDR-E-MI-45956 |
| MNDR | hsa-miR-376a-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-45957 |
| MNDR | hsa-miR-376a-3p | Prostate cancer | MNDR-E-MI-45958 |
| MNDR | hsa-miR-376a-3p | Gastric cancer | MNDR-E-MI-45959 |
| MNDR | hsa-miR-376a-3p | Alzheimer disease | MNDR-E-MI-45960 |
| MNDR | hsa-miR-376a-3p | Bladder cancer | MNDR-E-MI-45961 |
| MNDR | hsa-miR-376a-3p | Dysautonomia familial | MNDR-E-MI-45962 |
| MNDR | hsa-miR-376a-3p | Distal muscular dystrophy | MNDR-E-MI-45963 |
| MNDR | hsa-miR-376a-3p | Myotonic dystrophy | MNDR-E-MI-45964 |
| MNDR | hsa-miR-376a-3p | Duchenne muscular dystrophy | MNDR-E-MI-45965 |
| MNDR | hsa-miR-376a-3p | Cardiovascular disease | MNDR-E-MI-45966 |
| MNDR | hsa-miR-376a-3p | Lung cancer | MNDR-E-MI-45967 |
| MNDR | hsa-miR-376a-3p | Down syndrome | MNDR-E-MI-45968 |
| MNDR | hsa-miR-376a-3p | Parkinson disease | MNDR-E-MI-45969 |
| MNDR | hsa-miR-376a-3p | Basal-like breast cancer | MNDR-E-MI-45970 |
| MNDR | hsa-miR-376a-3p | Thyroid cancer | MNDR-E-MI-45971 |
| MNDR | hsa-miR-376a-3p | Pancreatic cancer | MNDR-E-MI-45972 |
| MNDR | hsa-miR-376a-3p | Melanoma | MNDR-E-MI-45973 |
| MNDR | hsa-miR-376a-3p | Giant cell tumor | MNDR-E-MI-45974 |
| MNDR | hsa-miR-376a-3p | Nephroblastoma | MNDR-E-MI-45975 |
| MNDR | hsa-miR-376a-3p | Colon adenocarcinoma | MNDR-E-MI-45976 |
| MNDR | hsa-miR-376a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-45977 |
| MNDR | hsa-miR-376a-3p | Familial ovarian cancer | MNDR-E-MI-45978 |
| MNDR | hsa-miR-376a-3p | Glioblastoma | MNDR-E-MI-45979 |
| MNDR | hsa-miR-376a-3p | Astrocytoma | MNDR-E-MI-45980 |
| MNDR | hsa-miR-376a-3p | Glioma | MNDR-E-MI-45981 |
| MNDR | hsa-miR-376a-3p | Nemaline myopathy | MNDR-E-MI-45982 |
| MNDR | hsa-miR-376a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-45983 |
| MNDR | hsa-miR-376a-3p | Osteosarcoma | MNDR-E-MI-45984 |
| MNDR | hsa-miR-376a-3p | Liposarcoma | MNDR-E-MI-45985 |
| MNDR | hsa-miR-376a-3p | Meningioma | MNDR-E-MI-45986 |
| MNDR | hsa-miR-376a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-45987 |
| MNDR | hsa-miR-376a-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-45988 |
| MNDR | hsa-miR-376a-3p | Adrenocortical cancer | MNDR-E-MI-45989 |
| MNDR | hsa-miR-376a-3p | Bladder urothelial carcinoma | MNDR-E-MI-45990 |
| MNDR | hsa-miR-376a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-45991 |
| MNDR | hsa-miR-376a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-45992 |
| MNDR | hsa-miR-376a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-45993 |
| MNDR | hsa-miR-376a-3p | Cholangiocarcinoma | MNDR-E-MI-45994 |
| MNDR | hsa-miR-376a-3p | Esophageal cancer | MNDR-E-MI-45995 |
| MNDR | hsa-miR-376a-3p | Synovial sarcoma | MNDR-E-MI-45996 |
| MNDR | hsa-miR-376a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-45997 |
| MNDR | hsa-miR-376a-3p | Hepatocellular carcinoma | MNDR-E-MI-45998 |
| MNDR | hsa-miR-376a-3p | Familiar ovarian carcinoma | MNDR-E-MI-45999 |
| MNDR | hsa-miR-376a-3p | B-cell lymphoma | MNDR-E-MI-46000 |
| MNDR | hsa-miR-376a-3p | Barrett's adenocarcinoma | MNDR-E-MI-46001 |
| MNDR | hsa-miR-376a-3p | Hodgkin lymphoma | MNDR-E-MI-46002 |
| MNDR | hsa-miR-376a-3p | Crohn disease | MNDR-E-MI-46003 |
| MNDR | hsa-miR-376a-3p | Colorectal cancer | MNDR-E-MI-46004 |
| MNDR | hsa-miR-376a-3p | Ovarian epithelial cancer | MNDR-E-MI-46005 |
| MNDR | hsa-miR-376a-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-46006 |
| MNDR | hsa-miR-376a-3p | Barrett's carcinogenesis | MNDR-E-MI-46007 |
| MNDR | hsa-miR-376a-3p | Breast cancer her3+ negative | MNDR-E-MI-46008 |
| MNDR | hsa-miR-376a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-46009 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR1C | Homo sapiens | RR00039082 |
TOP